• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算机模拟分析比较不同医学体系中治疗猪流感所开各类药物的疗效。

In Silico Analysis to Compare the Effectiveness of Assorted Drugs Prescribed for Swine flu in Diverse Medicine Systems.

作者信息

Raja Kalpana, Prabahar Archana, Selvakumar Suganya, Raja T K

机构信息

Departments of Plant Molecular Biology and Biotechnology, Centre for Plant Molecular Biology, Tamil Nadu Agricultural University, Coimbatore-641 003, India.

Department of Biotechnology, PSG College of Technology, Coimbatore-641 004, India.

出版信息

Indian J Pharm Sci. 2014 Jan;76(1):10-8.

PMID:24799734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4007250/
Abstract

The genome of the virus H1N1 2009 consists of eight segments but maximum number of mutations occurs at segments 1 and 4, coding for PB2 subunit of hemagglutinin. Comparatively less number of mutations occur at segment 6, coding for neuraminidase. Two antiviral drugs, oseltamivir and zanamivir are commonly prescribed for treating H1N1 infection. Alternate medical systems do compete equally; andrographolide in Siddha and gelsemine in Homeopathy. Recent studies confirm the efficacy of eugenol from Tulsi and vitamins C and E against H1N1. As the protein structures are unavailable, we modeled them using Modeller by identifying suitable templates, 1RUY and 3BEQ, for hemagglutinin and neuraminidase, respectively. Prior to docking simulations using AutoDock, the drug likeness properties of the ligands were screened using in silico techniques. Docking results showed interaction between the proteins individually into selected ligands, except for gelsemine and vitamin E no interactions were shown. The best docking simulation was reported by vitamin C interacting through six hydrogen bonds into proteins hemagglutinin and neuraminidase with binding energies -4.28 and -4.56 kcal/mol, respectively. Furthermore, vitamin C showed hydrophobic interactions with both proteins, two bonds with Arg119, Glu120 of HA, and one bond with Arg74 of NA. In silico docking studies thus recommend vitamin C to be more effective against H1N1.

摘要

2009年甲型H1N1流感病毒的基因组由八个片段组成,但1号和4号片段发生的突变最多,这两个片段编码血凝素的PB2亚基。相比之下,编码神经氨酸酶的6号片段发生的突变较少。两种抗病毒药物,即奥司他韦和扎那米韦,常用于治疗甲型H1N1流感感染。替代医学体系也同样具有竞争力;印度 Siddha 医学中的穿心莲内酯和顺势疗法中的钩吻碱。最近的研究证实了罗勒中的丁香酚以及维生素C和E对甲型H1N1流感的疗效。由于蛋白质结构不可用,我们通过分别为血凝素和神经氨酸酶识别合适的模板1RUY和3BEQ,使用Modeller对它们进行建模。在使用AutoDock进行对接模拟之前,使用计算机技术筛选配体的类药性质。对接结果显示蛋白质分别与选定的配体之间存在相互作用,除了钩吻碱和维生素E没有显示相互作用。据报道,维生素C通过六个氢键与血凝素和神经氨酸酶蛋白相互作用,结合能分别为-4.28和-4.56千卡/摩尔,是最佳对接模拟。此外,维生素C与两种蛋白质都表现出疏水相互作用,与血凝素的Arg119、Glu120形成两个键,与神经氨酸酶的Arg74形成一个键。因此,计算机对接研究表明维生素C对甲型H1N1流感更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/05f53b6d3d28/IJPhS-76-10-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/d88d538b9eee/IJPhS-76-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/cb5fe59bd220/IJPhS-76-10-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/05f53b6d3d28/IJPhS-76-10-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/d88d538b9eee/IJPhS-76-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/cb5fe59bd220/IJPhS-76-10-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f16d/4007250/05f53b6d3d28/IJPhS-76-10-g007.jpg

相似文献

1
In Silico Analysis to Compare the Effectiveness of Assorted Drugs Prescribed for Swine flu in Diverse Medicine Systems.通过计算机模拟分析比较不同医学体系中治疗猪流感所开各类药物的疗效。
Indian J Pharm Sci. 2014 Jan;76(1):10-8.
2
In silico genome analysis and drug efficacy test of influenza A virus (H1N1) 2009.甲型 H1N1 流感病毒的计算机基因组分析与药物疗效测试。
Indian J Microbiol. 2009 Dec;49(4):358-64. doi: 10.1007/s12088-009-0063-4. Epub 2010 Jan 7.
3
Analyzing the interaction of a herbal compound Andrographolide from as a folklore against swine flu (H1N1).分析一种来自民间治疗猪流感(H1N1)的草药化合物穿心莲内酯的相互作用。
Asian Pac J Trop Dis. 2014 Sep;4:S624-S630. doi: 10.1016/S2222-1808(14)60692-7. Epub 2014 Oct 6.
4
Molecular docking of selected phytocompounds with H1N1 Proteins.所选植物化合物与H1N1蛋白的分子对接
Bioinformation. 2015 Apr 30;11(4):196-202. doi: 10.6026/97320630011196. eCollection 2015.
5
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦(达菲)与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
6
Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.德国 1981 年至 2008 年间分离的猪流感 A 病毒的神经氨酸酶抑制剂敏感性。
Med Microbiol Immunol. 2012 Feb;201(1):61-72. doi: 10.1007/s00430-011-0206-1. Epub 2011 Jun 19.
7
Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.长时标 GPU 动力学揭示了 H1N1-2009 流感病毒双重突变体 I223R/H275Y 神经氨酸酶耐药机制。
Biochemistry. 2012 May 29;51(21):4364-75. doi: 10.1021/bi300561n. Epub 2012 May 17.
8
Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.新型甲型流感(H7N9)病毒神经氨酸酶与目前已批准的神经氨酸酶抑制剂奥司他韦、扎那米韦和帕拉米韦在突变 R289K 存在下的相互作用的结构分析。
BMC Bioinformatics. 2013;14 Suppl 16(Suppl 16):S7. doi: 10.1186/1471-2105-14-S16-S7. Epub 2013 Oct 22.
9
In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein.基于 S247R 突变的甲型 H1N1 流感神经氨酸酶蛋白的耐药性的计算机预测。
J Biomol Struct Dyn. 2018 Mar;36(4):966-980. doi: 10.1080/07391102.2017.1305295. Epub 2017 Apr 10.
10
Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach.神经氨酸酶(NA)抑制剂对不同地理区域 H1N1 株的疗效:一种计算机模拟方法。
Indian J Microbiol. 2009 Dec;49(4):370-6. doi: 10.1007/s12088-009-0065-2. Epub 2010 Jan 7.

引用本文的文献

1
Deciphering the therapeutic effects of Xiyanping injection: insights into pulmonary and gut microbiome modulation, SerpinB2/PAI-2 targeting, and alleviation of influenza a virus-induced lung injury.解读喜炎平注射液的治疗作用:对肺和肠道微生物群调节、丝氨酸蛋白酶抑制剂B2/纤溶酶原激活物抑制剂-2靶向作用以及减轻甲型流感病毒诱导的肺损伤的见解
Virol J. 2025 Jan 28;22(1):19. doi: 10.1186/s12985-025-02636-7.
2
Antiviral Activities of Andrographolide and Its Derivatives: Mechanism of Action and Delivery System.穿心莲内酯及其衍生物的抗病毒活性:作用机制与递送系统
Pharmaceuticals (Basel). 2021 Oct 28;14(11):1102. doi: 10.3390/ph14111102.
3

本文引用的文献

1
In silico genome analysis and drug efficacy test of influenza A virus (H1N1) 2009.甲型 H1N1 流感病毒的计算机基因组分析与药物疗效测试。
Indian J Microbiol. 2009 Dec;49(4):358-64. doi: 10.1007/s12088-009-0063-4. Epub 2010 Jan 7.
2
Swine flu virus H1N1: a threat to human health.甲型H1N1流感病毒:对人类健康的一种威胁。
Indian J Microbiol. 2009 Jun;49(2):201. doi: 10.1007/s12088-009-0040-y. Epub 2009 Jul 1.
3
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.2009年甲型H1N1流感大流行病毒感染的临床特征
Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial.
喜炎平注射液治疗 COVID-19 的疗效和安全性:一项多中心、前瞻性、开放标签、随机对照试验。
Phytother Res. 2021 Aug;35(8):4401-4410. doi: 10.1002/ptr.7141. Epub 2021 May 12.
N Engl J Med. 2010 May 6;362(18):1708-19. doi: 10.1056/NEJMra1000449.
4
Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1).猪流感病毒的多样性与新型人甲型流感病毒(H1N1)的出现。
Influenza Other Respir Viruses. 2009 Sep;3(5):207-13. doi: 10.1111/j.1750-2659.2009.00096.x.
5
Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.穿心莲内酯及其衍生物抗流感病毒的体内外活性。
Biol Pharm Bull. 2009 Aug;32(8):1385-91. doi: 10.1248/bpb.32.1385.
6
The persistent legacy of the 1918 influenza virus.1918年流感病毒的持续影响。
N Engl J Med. 2009 Jul 16;361(3):225-9. doi: 10.1056/NEJMp0904819. Epub 2009 Jun 29.
7
Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus.2009年甲型H1N1流感病毒的地理分布、监测及起源
N Engl J Med. 2009 Jul 9;361(2):115-9. doi: 10.1056/NEJMp0904572. Epub 2009 May 27.
8
Global transmission of oseltamivir-resistant influenza.耐奥司他韦流感病毒的全球传播。
N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2.
9
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.12种新一代抗抑郁药的疗效与可接受性比较:一项多治疗组元分析
Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5.
10
Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.2000年至2007年期间,某地区八次流感流行期间甲型流感病毒的分子进化
Arch Virol. 2009;154(2):285-95. doi: 10.1007/s00705-009-0309-9. Epub 2009 Jan 20.